Pharmaceutical Process Engineers are key players in the pharmaceutical industry, responsible for designing, developing, and scaling up processes to manufacture drugs efficiently and safely. They apply principles of catalysis and chemical engineering to optimize the synthesis of active pharmaceutical ingredients (APIs) and formulation processes, ensuring high product purity and consistency. Their expertise helps in meeting rigorous regulatory requirements while maximizing production yield and minimizing costs.
By utilizing advanced process simulation, modeling, and analytical tools, pharmaceutical process engineers fine-tune reaction conditions, separation techniques, and purification steps to achieve optimal performance. They work closely with chemists, quality assurance specialists, and regulatory bodies to translate laboratory-scale innovations into reliable commercial-scale manufacturing processes. Emphasizing sustainability, they integrate green chemistry approaches by employing energy-efficient catalytic reactions and minimizing waste generation. Their contributions not only accelerate drug development timelines but also improve environmental compliance and product safety. Continual innovation and process intensification strategies allow pharmaceutical process engineers to enhance production efficiency and adapt to evolving industry demands. Their work ultimately ensures the delivery of safe, effective, and affordable medications to patients worldwide. Additionally, they are instrumental in implementing continuous manufacturing technologies that improve process control and reduce production time. They also focus on scaling up biocatalytic processes, supporting the growth of biopharmaceuticals. Their role is critical in driving pharmaceutical innovation while maintaining strict safety and quality standards.
Title : Distant binuclear vanadium V(II) cationic sites in zeolites and their reactivity
Jiri Dedecek, J Heyrovsky Institute of Physical Chemistry , Czech Republic
Title : Advanced nanostructures for carbon neutrality and sustainable H₂ energy
Tokeer Ahmad, Jamia Millia Islamia, India
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model via bi-odesign, bio- and chemical engineering, translational applications, and upgraded business modeling to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as a generation of unique biomarkers, biocatalysts, potential targets and translational tools towards nanodesign-driven biochemical engineering and precision medical practice
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Dimethyl ether synthesis from syngas over Cu-Zn/Al2O3 catalysts prepared using the Sol-Gel method
Uday Som, Research and Development Engineer, Japan
Title : Influence of various catalysts on H₂ enhancement and CO2 capture during syngas upgrading
Enrico Paris, CREA-IT & DIAEE, Italy
Title : Photoaligned azodye nanolayers : New nanotechnology for liquid crystal devices
Vladimir G Chigrinov, Hong Kong University of Science and Technology, Russian Federation
Title : Application of vanadium, tantalum and chromium single-site zeolite catalysts in catalysis
Stanislaw Dzwigaj, Sorbonne University, France
Title : Oxidation of methane to methanol over pairs of transition metal ions stabilized in the zeolite matrices
Jiri Dedecek, J Heyrovsky Institute of Physical Chemistry , Czech Republic
Title : The Concept and Implications of Low Carbon Green Growth
Dai Yeun Jeong, Asia Climate Change Education Center, Korea, Republic of